tert-butyl-quinazolin-4-yl-amine | 22754-18-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: tert-butyl-quinazolin-4-yl-amine
• 英文别名: 4-(tert-butylamino)quinazoline；tert-butyl-quinazolin-4-yl-amine；4-tert.Butylamino-chinazolin；N-tert-butylquinazolin-4-amine
• CAS: 22754-18-3
• 化学式: C₁₂H₁₅N₃
• mdl: MFCD02363946
• 分子量: 201.271
• InChiKey: PMIVDVXNMLOJNN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  37.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-羟基喹唑啉 在 六氯环三磷腈 、 N,N-二异丙基乙胺 作用下， 以 乙腈 为溶剂， 反应 25.0h， 生成 tert-butyl-quinazolin-4-yl-amine
  参考文献：
  名称：

  An efficient HCCP-mediated direct amination of quinazolin-4(3H)-ones

  摘要：

  An efficient direct amination of quinazolin-4(3H)-ones has been developed. Treatment of quinazolin-4(3H)-ones with HCCP, DIPEA, and N-contained nucleophiles in acetonitrile could be able to form the corresponding 4-aminoquinazoline derivatives. Under the optimal reaction conditions, the amination products were achieved in good yields. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2010.12.067

文献信息

• The Scope and Mechanism of Phosphonium-Mediated S_NAr Reactions in Heterocyclic Amides and Ureas
  作者：Zhao-Kui Wan、Sumrit Wacharasindhu、Christopher G. Levins、Melissa Lin、Keiko Tabei、Tarek S. Mansour

  DOI：10.1021/jo7020373

  日期：2007.12.1

  An efficient “one-step” synthesis of cyclic amidines and guanidines has been developed. Treatment of cyclic amides and ureas with benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP), base, and nitrogen nucleophiles leads to the formation of the corresponding cyclic amidines and guanidines, typically in good to excellent yields. This method has also been used to prepare heteroaryl

  已经开发了有效的“一步”合成环状am和胍的方法。用六氟磷酸苯并三唑-1-基氧基三（二甲氨基）phosph，碱和氮亲核试剂处理环状酰胺和脲会导致形成相应的环状typically和胍，通常收率高至优异。该方法也已经用于使用苯酚和硫代苯酚亲核试剂制备杂芳基醚和硫醚。时程NMR和HPLC-MS研究促进了所提出的中间体（phospho盐和HOBt加合物）的明确表征。数据揭示了逐步的反应途径。
• Small molecule inhibitors of EGFR and PI3K
  申请人：The Regents of the University of Michigan

  公开号：US10206924B2

  公开（公告）日：2019-02-19

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a quinazoline structure or a quinoline structure which function as dual inhibitors of EGFR proteins and PI3K proteins, and their use as therapeutics for the treatment of cancer and other diseases.

  本发明属于药物化学领域。特别是，本发明涉及一类具有喹唑啉结构或喹啉结构的新型小分子，它们可作为表皮生长因子受体蛋白和 PI3K 蛋白的双重抑制剂，并可用作治疗癌症和其他疾病的疗法。
• An Efficient Direct Amination of Cyclic Amides and Cyclic Ureas
  作者：Zhao-Kui Wan、Sumrit Wacharasindhu、Eva Binnun、Tarek Mansour

  DOI：10.1021/ol060815y

  日期：2006.5.1

  [graphics]An efficient one-step amination of cyclic amides and ureas has been developed. Treatment of cyclic amides and cyclic ureas with BOP in the presence of DBU in various solvents led to the formation of cyclic amidines and cyclic guanidines in good to excellent yields. Concise syntheses of biologically intriguing kinetin and potent kinase inhibitor olomoucin were thus achieved in just one and two steps, respectively.
• BROWN D. J.; IENAGA K., J. CHEM. SOC. PERKIN TRANS. PART 1, <JCPK-BH>, 1975, NO 21, 2182-2185
  作者：BROWN D. J.、 IENAGA K.

  DOI：——

  日期：——
• SMALL MOLECULE INHIBITORS OF EGFR AND PI3K
  申请人：The Regents of the University of Michigan

  公开号：US20170360788A1

  公开（公告）日：2017-12-21

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a quinazoline structure or a quinoline structure which function as dual inhibitors of EGFR proteins and PI3K proteins, and their use as therapeutics for the treatment of cancer and other diseases.